Objective: The purpose of the present longitudinal study was to describe the associations between the 5-year changes in body mass index (BMI) and alterations in the clusters of metabolic syndrome (MS)-related factors. Methods: The study population comprised 1099 middle-aged adults drawn from the Stanislas study. Individuals were stratified into four groups according to the 5-year changes in BMI (weight loss (o0 kg/m 2 ), and weight gain (0-1, 1-2 and 42 kg/m 2 )). Changes in various MS-related variables and clusters were compared between groups: anthropometric indices, blood pressure, lipid and inflammatory markers, liver enzymes, uric acid and the five summary factors extracted by using factor analysis ('risk lipids', 'liver enzymes', 'inflammation', 'protective lipids' and 'blood pressure').
Introduction
According to the World Health Organization and the National Institute of Health, obesity is becoming one of the most important contributors to ill health 1 and excess body mass and adiposity are associated with poor health status and various chronic diseases. 2 It has been largely reported that the risk of death from cardiovascular diseases, cancer, or other diseases increases with the severity of obesity in both men and women in all age groups. 3 To investigate the association between body fat mass and adiposity excess on cardiovascular diseases, several population-based studies evaluated the relationships of changes in anthropometric parameters with the metabolic syndrome (MS)-associated factors. Weight gain is accompanied by the early and more aggressive manifestations of well-recognized risk factors for atherosclerotic cardiovascular disease: blood pressure, [4] [5] [6] [7] lipid profile, 4, 5, [7] [8] [9] blood glucose and insulin resistance, 10 inflammatory biomarkers such as high-sensitivity C-reactive protein (hs-CRP), 11, 12 liver enzymes such as g-glutamyl transferase (GGT) 13 and uric acid. 14, 15 Conversely, weight loss improves cardiometabolic risk. However, no study has yet investigated simultaneously, in the same sample population, the relationships of body mass index (BMI) changes on a set of common and newly MS-related factors, by taking additionally gender into account. Thus, in this study, we describe the associations between the 5-year changes in BMI and alterations in various MSrelated factors in 1099 middle-aged adults stratified by sex. In addition, five summary clusters based on cardiometabolic factors and extracted by using factor analysis were analyzed according to short-term BMI changes.
Methods

Subjects
This study is part of the Stanislas Family Study, a 10-year longitudinal follow-up study conducted since 1994 on 1006 families selected at the Center for Preventive Medicine of Vandoeuvre-lès-Nancy (east of France). In this study, we present data from a subsample of 1099 middle-aged adults (aged 30-64 years at entrance, 544 men and 555 women) 16 who had undergone health examinations in 1994-1995 (entrance) and in 1999-2000 (second checkup). In the two separated groups of men and women, individuals were unrelated to each other. Owing to the design of the Stanislas Family Study, subjects were of French origin and were free from acute or chronic diseases such as stroke, myocardial infarction or cancer. Additional exclusion criteria were used for avoiding potential effects on metabolic values and consequently on results of the factor analysis: moderate and severe thinness (BMIo17 kg/m 2 ), severe obesity (class III obesity: BMIX40 kg/m 2 ), 17 alcohol abuse (consumption
, liver enzyme abnormalities (aspartate aminotransferase (ASAT) X120 U l
À1
, alanine aminotransferase (ALAT) or GGT activities X200 U l À1 ), acute inflammation (serum orosomucoid X2.5 g l À1 , serum haptoglobin X3.5 g l
, serum hs-CRP X15 mg l
), severe dyslipidemia (serum cholesterol or triglycerides concentrations X10 mmol l À1 ), hyperglycemia or diabetes (serum glucose X8 mmol l À1 or the use of antidiabetic agent), severe hypertension (systolic blood pressure X185 mm Hg or diastolic blood pressure X120 mm Hg). A total of 1653 individuals (about 50% women) participated in the baseline examination and had not missing values for all the above-mentioned variables. The response rate for the second checkup was 73% (1207 subjects). And finally, accounting for exclusion criteria used at entrance and at the second checkup, 1099 individuals were eligible for this study.
Women who attended the follow-up examination were similar to those who did not attend for all the characteristics, except for age: nonresponders were significantly younger than the others. Conversely, men who did not attend the second checkup had significant higher mean values for waist-to-hip ratio (WHR), cigarette consumption, fasting glucose, triglycerides, apolipoprotein E, uric acid, haptoglobin, orosomucoid, activities of ASAT, ALAT, alkaline phosphatase (ALP) and GGT, and white blood cells (WBC) count. Moreover, they were significantly younger than the responders.
Each subject gave written informed consent for participating in this study, which was approved by the 'Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale de Lorraine' (France). In addition, we certify that all applicable governmental regulations concerning the ethical use of human volunteers were followed during this research.
Blood samples and data collection Data were collected by using relevant questionnaires including information about lifestyle such as tobacco, alcohol and drug consumption and personal medical history. Physical examinations and functional tests were performed and basic blood constituents were measured as described previously. 18 Weight and height were measured while the participants were standing in light clothing without shoes. Weight was recorded with digital scales and recorded to the nearest 200 g. Height was measured to the nearest 0.1 cm by using wall-mounted stadiometers, while the subjects had the shoulders in a normal position. BMI was calculated as weight in kilograms divided by height in squared meters. To reduce error, all measurements were taken by trained nurses according to the standard procedures established by the Center for Preventive Medicine. Examination of the reliability of the measuring devices was performed periodically during all the study period.
Waist girth was measured at the narrowest level, and hip girth was measured at the maximum level over light clothing, by using an unstretched tape measure, without any pressure to body surface; measurements were recorded to the nearest 0.1 cm.
Physical activity was calculated by using the responses to two items (three choice questions) of the self-questionnaire of the Stanislas study about work activity and leisure time activity. Information was merged and expressed in three grades of activity: low ¼ 1, moderate ¼ 2 and high ¼ 3.
Serum concentrations of fasting glucose, total cholesterol, triglycerides and activities of ASAT, ALAT, ALP and GGT were measured with commercially available kits on an AU5021 apparatus (all from Merck, Darmstadt, Germany) on fresh aliquots, and within 2 h. Serum apolipoproteins AI and B, hs-CRP, haptoglobin and orosomucoid were measured by immunonephelometry on a Behring Nephelometer Analyser (BN II, Dade-Behring, Marburg, Germany) with Behring reagents (Dade-Behring, Reuil-Malmaison, France) within 2 h after sampling. All the blood measurements at entrance and at the second checkup were performed in the same laboratory (Center for Preventive Medicine of Vandoeuvre les Nancy, France) and monitored by using the National Quality Control from France.
Statistical analyses
Statistical analyses were performed by using the SAS software package version 9.1 (SAS Institute Inc., Cary, NC, USA). Before statistical analyses, serum concentrations of the above mentioned variables were adjusted for the effect of betweenmonth variability to remove the effect of both seasonal and analytical variations. Briefly, for each variable, levels were regressed on monthly truncated means obtained on selected healthy men aged 20-40 years attending the health checkup concurrently with the sample population of this study; the variable used being the sum: residual þ crude mean of the overall sample.
As the distributions of triglycerides, apolipoprotein E, hs-CRP concentrations and ASAT, ALAT and GGT activities BMI changes and MS-related clusters H Berrahmoune et al exhibited a long-tailed positive skewness and kurtosis both at entrance and at the second checkup, log 10 transformation was used. Conversely, the 5-year changes for all variables had normal distributions. The Gaussian distribution was verified by using normal probability plots. For continuous variables at entrance, Kruskal-Wallis tests were performed for characteristic differences across the four groups of BMI changes (weight loss (o0 kg/m 2 ), and weight gain (0-1, 1-2 and 42 kg/m 2 )). The significance of differences among the groups for the categorical variables was analyzed by using the w 2 -test when cells had expected counts greater than five. The 5-year changes in MS-related variables according to the four BMI change groups were tested by using the test for trend after the adjustment for variable level, age, BMI, alcohol and cigarette consumption at entrance, and the 5-year changes in alcohol and cigarette consumption. In addition, test for interaction between sex and BMI changes was performed. Associations between risk variables related to MS (biological variables and blood pressure) were determined by using Pearson correlation analysis in the whole group (men and women) after adjustment for age, sex and variable value at entrance.
Factor analysis was used to extract factors, followed by orthogonal (varimax) rotation to assist in the interpretation of the factors and to ensure that the factors were uncorrelated. Five-year changes of the following variables were included: serum triglycerides, total cholesterol, HDL cholesterol, apolipoproteins A1, B and E, fasting glucose, hs-CRP, orosomucoid and haptoglobin concentrations; ALAT, ASAT, ALP and GGT activities; WBC count; systolic and diastolic blood pressure. As the values for waist girth or WHR were significantly correlated with BMI, both at entrance and for the 5-year changes, these two anthropometric parameters were not included in factor analysis. Co-linearity between waist girth, WHR and BMI would give wrong results in the following statistical analysis. Variables were adjusted for age, sex and entrance value before analysis. Variables with factor loadings having absolute values of 0.20 or greater were used in interpreting the factors. Scores were computed for rotated factors as the sum of products of observed variables multiplied by their factor loading. Finally, these scores were analyzed according to the four categories of BMI changes. Statistical significance was taken at Pp0.05.
Results
Baseline characteristics by BMI change categories Kruskal-Wallis test showed significant differences across the four categories of BMI changes (Table 1) for all baseline anthropometrical indices (BMI, weight, weight girth and WHR) in both men and women (Pp0.05), for baseline alcohol consumption, HDL-cholesterol concentration and WBC count in women (P ¼ 0.012, P ¼ 0.004, and P ¼ 0.003, respectively) and apolipoprotein B and fasting glucose concentration in men (P ¼ 0.041 and P ¼ 0.004, respectively). These results required the adjustment for baseline characteristics before further analysis of changes in variables of interest.
Five-year changes in MS-related variables by BMI change categories Changes in anthropometrical parameters described in Table 2 were strongly associated with BMI gain in men and in women (Pp0.001). Changes in cigarette consumption significantly differed across the four groups (decrease of cigarette number when BMI increased), whereas the changes in alcohol consumption and activity index did not. There was a strong significant linear trend with the increasing BMI and worsening of the following MS-related variables in both men and women: systolic and diastolic blood pressure; serum triglycerides, total cholesterol, HDL-cholesterol, apolipoprotein B, apolipoprotein E, uric acid and orosomucoid concentrations, GGT activity and WBC count. In addition, in men only, the same significant trend was observed for concentrations of apolipoproteins A1 and for ASAT and ALAT activities; whereas in women, the relationships were significant for ALP activity and serum concentrations of hs-CRP and haptoglobin. Interaction terms with sex were significant for triglycerides, apolipoprotein E, haptoglobin and orosomucoid concentrations and ASAT, ALAT, GGT and ALP activities. Table 3 presents the correlation matrix for the changes of the various MS-related variables. Changes in anthropometrical parameters over 5 years were strongly correlated between them (BMI, WHR and waist girth; Pp0.001) and with most of the MS-related variables (Table 3) . Systolic blood pressure, diastolic blood pressure, apolipoprotein E and blood glucose were significantly related to BMI and waist girth, but not to WHR changes. WBC were significantly correlated with WHR and waist girth changes and not with BMI gain.
Correlation matrix for variable changes
Exploratory factor analysis
Principal component analysis identified five factors with proportion of the explained variance 410% (40.8, 21.8, 19.9, 13.2 and 11.5%, for factor 1-5, respectively), that were retained for factor rotation. Factor loadings of the original variables with each factor after varimax rotation are shown in Table 4 . The variables' changes over 5 years were loaded in each factor with a factor loading X0.20. These factors were interpreted and named as (1) 'risk lipids', with positive loadings of apolipoprotein B, total cholesterol, apolipoprotein E, triglycerides, uric acid and GGT; (2) 'liver enzymes', represented by ALAT, ASAT and GGT; (3) 'inflammation', represented by orosomucoid, haptoglobin, hs-CRP, ALP and WBC; (4) 'protective lipids', represented by HDL-cholesterol, BMI changes and MS-related clusters H Berrahmoune et al 
BMI changes and MS-related clusters
H Berrahmoune et al Table 2 The 5-year changes in metabolic syndrome-related variables by categories of the 5-year changes in BMI P-value for men. b P-value for women, differences across the four groups: test for trend by using the adjusted values for variable level, age, BMI, alcohol and cigarette consumption at entrance, and the 5-year change in alcohol and cigarette consumption except for weight, BMI, waist girth, alcohol, tobacco and activity. c P-test for the interaction between sex and categories of the BMI changes. ALAT ¼ alanine aminotransferase; ALP ¼ alkaline phosphatase; ASAT ¼ aspartate aminotransferase; BMI ¼ body mass index; DBP ¼ diastolic blood pressure; GGT ¼ g-glutamyl transferase; HDL ¼ high-density lipoprotein; hs-CRP ¼ high-sensitivity C-reactive protein; SBP ¼ systolic blood pressure; WBC ¼ white blood cells; WHR ¼ waist-to-hip ratio. a Variables were adjusted for age, sex and entrance value before the analysis. For n ¼ 1099, minimum significant correlation coefficients at P ¼ 0.05, 0.01 and 0.001 were 0.058, 0.076 and 0.097, respectively. apolipoprotein A1, cholesterol and triglycerides (negative value) and (5) 'blood pressure' with positive loadings of diastolic and systolic blood pressures and fasting glucose.
Men
n ¼ 121 n ¼ 198 n ¼ 145 n ¼ 80 n ¼ 125 n ¼ 182 n ¼ 123 n ¼ 125 DWeight (kg) À2.2 ± 2.3 1.4 ± 1.0 4.2 ± 1.2 8.8 ± 3.3 p0.
BMI changes and MS-related clusters H Berrahmoune et al
The five factor scores by BMI change categories The association of factor scores across the four categories of the 5-year changes in BMI was assessed using the test for trend after the adjustment for age, BMI, alcohol and cigarette consumption at entrance, and the 5-year change in alcohol and cigarette consumption (Table 5 ). There was a strong linear trend between increasing BMI gain and worsening of risk lipids and blood pressure factors among men and women (Pp0.001). In addition, in men only, liver enzymes and protective lipids factors were significantly related to the 5-year gain in BMI (Pp0.001); whereas the inflammation factor positively increased across the four BMI-change groups, in women only. Interaction terms with sex were statistically significant for the factors inflammation and liver enzymes (Pp0.001) and borderline significant for protective lipids (P ¼ 0.07).
Similar results were found for the five scores when analyses were successively restricted to individuals not taking the following drugs (lipid-lowering medications, aspirin, oral contraceptive or hormone replacement therapy), not having menopause, or smoking less than five cigarettes per day. However, later with alcohol consumption higher than 24 g per day (about 1/4 l wine), differences across the four categories of the 5-year changes in BMI were less marked for protective lipids in men only: 0.05 ± 0.72, 0.04 ± 0.68, À0.18 ± 0.79 and À0.14 ± 0.80 (P ¼ 0.05). In addition, interaction term with sex in test for trend was no longer significant. For the scores risk lipids, liver enzymes, inflammation and blood pressure, exclusion of subjects consuming more than 24 g of alcohol per day did not modify our previous results shown in Table 5 .
Discussion
In this study, we described in which way the 5-year changes in a sizeable number of MS-related variables are associated each other and how alterations in BMI are related with these changes. We not only confirmed but also extended previously reported works about the relationships between BMI gain and worsening of various MS-related variables in men and/or in women including blood pressure, lipid profile, inflammation markers, liver enzymes, uric acid and ALP activity. By using factor analysis in order to avoid the problem of multiple comparisons and redundancy of information, five summary factors based on the patterns of changes of the metabolic variables were identified: risk lipids, liver enzymes, inflammation, protective lipids and blood pressure. In addition, we showed a gender-dependent interaction between changes in BMI and MS-related clusters: liver enzymes and protective lipids factors were significantly associated with weight gain in men and inflammation in women, whereas risk lipids and blood pressure factors were related to weight gain in both men and women.
In contrast to previous investigations, 19 this survey was not designed to contribute to better diagnosis or prediction of the MS but to emphasize the impact of short-term changes Variables were adjusted for age, sex and entrance value before the analysis; varimax rotation were used. Factor loadings of less than 0.20 or more than -0.20 were not shown for simplicity.
BMI changes and MS-related clusters H Berrahmoune et al in BMI, on various MS-related factors and their clusters. The major findings of factor analysis were the confirmation of previously reported metabolic summary factors from crosssectional studies of nondiabetic healthy adults (risk and protective lipids, blood pressure and inflammation) 19, 20 and the identification of a new summary factor (liver enzymes). Moreover, in agreement with previous studies, WBC aggregated with inflammation markers (inflammation cluster) 21 and uric acid and GGT activity with lipid levels of risk lipids cluster. 22 When analyzing individual parameters or clusters taking the confounders into account, our results are in accordance with worldwide previous studies showing associations of blood pressure and lipid profile changes over time with changes in BMI for both sexes. 4, 6, 8, 23, 24 In addition, similarly to previous investigations, changes in GGT activity and uric acid concentrations 15 were significantly associated with BMI gain in both genders and no association was found with changes in fasting blood glucose levels. 4, 7 Conversely, BMI changes were associated with changes in ALP and in inflammatory markers (hs-CRP, haptoglobin, orosomucoid and summary cluster inflammation) in women only. A number of previous studies have underlined the differences between men and women for the associations between inflammation markers and body composition and/ or weight alteration. For instance, positive correlations of adiposity with hs-CRP concentrations are often stronger in women than in men [25] [26] [27] and hs-CRP concentrations have been found reduced with weight loss in women. 28 Data related to other inflammatory markers are scarce; orosomucoid and haptoglobin concentrations have been shown to be associated with weight gain in a male population but without comparison with women. 29 The mechanisms acting for this sex-specific difference are not well understood but a possible explanation could be given by leptin. This adipokine plays important roles in regulating immune and inflammatory response 30 and recently Abdullah et al.
31
observed significant correlations between leptin and hs-CRP levels in women but not in men, independently of other measures of obesity. Significant associations were previously observed in men between ASAT, ALAT and GGT activities and BMI by using cross-sectional 23 or longitudinal design, 32 after controlling for the effect of alcohol consumption as in our study. Moreover, in agreement with our data, BMI changes over time were related to simultaneous alterations of ALAT, ASAT and GGT activities. 5 However, no sex-dependent interaction was noticed in the literature as in our study. Likewise, no data exists on relationships between ALP activity and BMI change, our results observed in women only could be due to bone formation mechanism related to hormonal status. 33 The gender-dependant associations, we found for inflammation and liver enzymes factors could be explained by gender-differences in adiposity. Intra-abdominal fat is closely connected anatomically and physiologically to the liver. 34 In men, it is related in a nonlinear way with weight, BMI, and Table 5 Average factor scores by categories of the 5-year changes in BMI in men and women BMI changes and MS-related clusters H Berrahmoune et al waist girth in normal weight individuals, whereas distribution of fat becomes more uniform across storage sites in obesity. Contrary to men, in women, this relationship is always linear in normal or higher BMI as a result of their generalized/peripheral fat patterning. 35 We can presume that equal weight gain, in nonexcessively obese men and women, could result in differential fat accumulation. Thus, a trend for intra-abdominal accumulation in men could affect liver metabolism and liver enzyme activity, whereas in women the trend for a more homogenous/generalized fat distribution could trigger inflammation, explaining at least partially, the sex-dependent relationship we evidenced.
The strengths of the current longitudinal study include the careful selection of the subsample of middle-aged adult, without chronic (cardiovascular diseases and diabetes) or acute disease, without morbid obesity and without extreme values concerning the MS-related variables. Furthermore, detailed information on lifestyle and metabolic factors were available and were used as confounding factors. Another strength is that the data collection at the two checkups was performed in the same center, by trained staff and according to standard procedures monitored by using a Quality Control program. In addition, seasonal and analytical variation variability was reduced and/or taken into account before statistical analyses.
This study is limited by the fact that our conclusions are valid for middle-aged adults living in the east France with similar characteristics and comparison with other investigations should take into account the characteristics of these French individuals. Another limitation is related to the usual problem of withdrawal in longitudinal surveys and differences at baseline between subjects attending only the first and both checkup visits. As we were not able to perform a recall for the subsample (or for a part of it) of nonresponders, no accurate estimation was available about the confounding effect on our results. Nevertheless, we can hypothesize that loss of individuals with higher MS-related factors (in particular in the group of men) has led to an underestimation of effects and to a subsequent reduction of statistical power.
In conclusion, our results show that short-term BMI gain is strongly associated with the worsening of various MS-related variables when analyzing them individually or after clustering. This association is significant for risk lipids and blood pressure factors for both men and women. Conversely, liver enzymes and protective lipids factors are significantly related to BMI gain in men only, whereas inflammation factor is associated with BMI gain in women only. This fact underlines the importance of gender in biological mechanisms involved in MS physiopathology.
